Skip to content
§OpenCFR
RulesCurrent RulesComingWhat's ComingGuidesAbout
Code of Federal Regulations › Title 21 › Part 809

Part 809 — In Vitro Diagnostic Products for Human Use

Current through Sep 8, 2026

Authority: 21 U.S.C. 321(h)(1), 331, 351, 352, 360, 360c, 360d, 360e, 360h, 360i, 360j, 371, 372, 374, 381, and 42 U.S.C. 262.

Sections

  • § 809.3 Definitions.
  • § 809.4 Confidentiality of submitted information.
  • § 809.10 Labeling for in vitro diagnostic products.
  • § 809.11 Exceptions or alternatives to labeling requirements for in vitro diagnostic products for human use held by the Strategic National Stockpile.
  • § 809.20 General requirements for manufacturers and producers of in vitro diagnostic products.
  • § 809.30 Restrictions on the sale, distribution and use of analyte specific reagents.
  • § 809.40 Restrictions on the sale, distribution, and use of OTC test sample collection systems for drugs of abuse testing.
Not legal advice. The eCFR is an editorially compiled, unofficial edition of the CFR; official editions are published by the Office of the Federal Register on govinfo.gov. About OpenCFR · Interpretation letters · Privacy